Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

(2020) L. Zhang et al.   ANNALS OF ONCOLOGY

COVID-19 outcomes in patients with hematologic disease

(2020) Florent Malard et al.   BONE MARROW TRANSPLANTATION

Care of haematology patients in a COVID‐19 epidemic

(2020) John Willan et al.   BRITISH JOURNAL OF HAEMATOLOGY

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

(2020) Lennard Y W Lee et al.   LANCET

Estimating case fatality rates of COVID-19

(2020) Piotr Spychalski et al.   LANCET INFECTIOUS DISEASES

COVID-19 in persons with haematological cancers

(2020) Wenjuan He et al.   LEUKEMIA

Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak

(2020) Mengyuan Dai et al.   Cancer Discovery

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

(2020) Vikas Mehta et al.   Cancer Discovery

Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus

(2012) Hans H. Hirsch et al.   CLINICAL INFECTIOUS DISEASES